1Life Healthcare

1Life Healthcare, Inc. engages in the provision of healthcare membership services. It offers walk-in immunizations and lab services, behavioral health, women's health, men’s health, LGBTQ+ care, pediatrics, sports medicine, lifestyle, and wellbeing programs. The company was founded by Thomas H. Lee on July 25, 2002 and is headquartered in San Francisco, CA.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

One Medical is a members-only technology platform offering an array of concierge medical services. The integration of these elements allows them to offer a seamless experience that not only saves their patients time and money but also leads to better health outcomes and happier lives. The company attracts the highest caliber team of healthcare providers, allowing them to practice medicine the way it should be. Each of their professionals has the time to invest in personal relationships and engage in thoughtful decision-making with their patients. One Medical makes access to care frictionless with face-to-face virtual video visits available anytime. It allows practicing medicine the way it should be practiced, focusing on improving the patient experience and challenging the healthcare status quo. One Medical was founded in 2007 and is headquartered in San Francisco, California, United States.

SAN FRANCISCO, Aug. 04, 2021 (GLOBE NEWSWIRE) -- 1Life Healthcare, Inc. (One Medical) (Nasdaq: ONEM) today announced financial results for the second quarter ended June 30, 2021.

One Medical Announces Results for Second Quarter 2021

1Life Healthcare, Inc. (ONEM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Will 1Life Healthcare, Inc. (ONEM) Report Negative Earnings Next Week? What You Should Know

Carnival

They are both trading at lows not seen in months.

Are These 2 Crashing Stocks Worth Buying on the Dip?

SAN FRANCISCO, July 16, 2021 (GLOBE NEWSWIRE) -- 1Life Healthcare, Inc. (One Medical) (Nasdaq: ONEM) today announced that its second quarter 2021 results will be released on Wednesday, August 4, 2021, after the close of the market. The company will host a conference call on the same day at 1:30 p.m. (PT) / 4:30 p.m. (ET) to discuss its financial results.

1Life Healthcare (One Medical) Announces Date of its Second Quarter 2021 Results Conference Call

Aerpio Pharmaceuticals Inc

Chiasma

Net Element

Soliton

Sykes Enterprises

NEW YORK , July 10, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: 1Life Healthcare, Inc. (NASDAQ: ONEM)  concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Iora Health. Under the terms of the merger, 1Life Healthcare will acquire Iora Health in an all-stock transaction.

INVESTIGATION ALERT: Halper Sadeh LLP Investigates ONEM, SYKE, NETE, CHMA, SOLY, ARPO; Shareholders are Encouraged to Contact the Firm

NEW YORK, July 8, 2021 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of 1Life Healthcare, Inc. ("One Medical" or the "Company") (NASDAQ: ONEM) in connection with the proposed merger of the Company with Iora Health, Inc. ("Iora"), a privately-held health care company.  Under the terms of the merger agreement, Iora shareholders will receive 56.1 million shares of One Medical common stock.

SHAREHOLDER ALERT: WeissLaw LLP Investigates 1Life Healthcare, Inc.

Primary care company One Medical has apologized after it sent out an email that exposed hundreds of customers' email addresses. The email sent out by One Medical on Wednesday asked to “verify your email,” but one email seen by TechCrunch had more than 980 email addresses copied on the email.

An email sent by One Medical exposed hundreds of customers' email addresses

The union would encompass 500 employees across the U.S.

Healthtech Company One Medical Announces Plan To Unionize

American Well Corporation

Teladoc

Few trends are as easily identifiable as the structural opportunity in the healthcare technology space. As a society, we have undergone a transformative experience as a society over the past year, with so many taken-for-granted facets of daily life halted, rearranged, and rebuilt in what ultimately may be a superior form.

The Opportunity in Disruptive Healthcare Stocks

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Iora Health to 1Life Healthcare, Inc. (NasdaqGS: ONEM) (“the Company”). Under the terms of the proposed transaction, 1Life is acquiring Iora Health in an all-stock transaction valued at approximately $2.1 billion. KSF is seeking to determine whether the merger and the process that led to it are adequate and fa

1LIFE HEALTHCARE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates 1Life Healthcare, Inc. - ONEM

1Life Healthcare has seen solid operating momentum in 2020 and early in 2021. A recent tick-up in losses and outlook for more modest sequential growth makes me a bit cautious.

1Life Healthcare: Some Questions After Recent Events

NEW YORK, June 8, 2021 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating 1Life Healthcare, Inc. ("ONEM" or the "Company") ( ONEM ) relating to its proposed acquisition of Iora Health, Inc. Under the terms of the agreement, ONEM shareholders will own approximately 73.25% of the combined company. The investigation focuses on whether 1Life Healthcare, Inc. and its Board of Directors violated securities laws and/or breached their fiduciary duties to the Company by 1) failing to conduct a fair process, and 2) whether the transaction is properly valued.

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of 1Life Healthcare, Inc. - ONEM

Philadelphia, Pennsylvania--(Newsfile Corp. - June 8, 2021) - Kaskela Law LLC announces that is investigating 1Life Healthcare, Inc. (One Medical) (NASDAQ: ONEM) on behalf of the Company's stockholders.On June 7, 2021, One Medical announced that it had entered into an agreement to acquire Iora Health in an all-stock transaction valued at approximately $2.1 billion. Under the terms of the agreement, Iora Health shareholders will receive 56.1 million shares of One Medical common stock. ...

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of 1Life Healthcare, Inc. (ONEM) and Encourages Stockholders to Contact the Firm

SAN FRANCISCO, June 08, 2021 (GLOBE NEWSWIRE) -- One Medical (NASDAQ: ONEM), a leading national technology-powered primary care organization, today announced the appointment of Scott C. Taylor to its board of directors. As the former Executive Vice President, General Counsel and Corporate Secretary of Symantec Corporation (now called NortonLifeLock), Mr. Taylor has deep expertise in corporate compliance and governance as well as acumen in government affairs, public policy, corporate responsibility, and philanthropy and ethics. He is a seasoned executive with decades of experience as a leader in numerous industries across various stages of business growth.

One Medical Appoints Scott C. Taylor to Board of Directors

1Life Healthcare announced it has entered into a definitive agreement to buy Iora Health in a $2.1 billion deal. These are the details.

One Medical (ONEM) Announces Deal To Buy Iora Health In $2.1 Billion Deal: Details

Primary care company One Medical plans to acquire competitor Iora Health for about $2.1 billion in a bid to reach a growing senior population, the company said on Monday.  One Medical, which went public in 2020, offers in-person and telehealth visits primarily to commercially insured patients who pay a membership fee. Iora Health is focused on senior patients in risk-sharing health plans, including through Medicare Advantage and Medicare direct contracting. Health plans typically pay Iora a flat fee per patient, whose care is overseen by doctors, nurses and health coaches.

One Medical is making a $2.1 billion bet on a rival that upended medical care for seniors

Iora Health focuses on Medicare and expands One Medical's business to commercial and Medicare segments as well as more regions, 1Life Healthcare Inc. said Monday.

One Medical to buy Iora Health for $2.1 billion

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger of 1Life Healthcare, Inc. (NASDAQ: ONEM) and Iora Health is fair to 1Life Healthcare shareholders. Under the terms of the merger, 1Life Healthcare will acquire Iora Health in an all-stock transaction. Upon closing, 1Life Healthcare shareholders are expected to own approximately 73.25% of the combined company. Halper Sadeh encourages 1Life Healthcare shareholders to click here to l

1Life Healthcare Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of 1Life Healthcare, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – ONEM

One Medical expands member-based, technology-powered primary care model to every stage of life, and extends into full-risk Medicare reimbursement models

One Medical Announces Agreement to Acquire Iora Health

Peer-reviewed study demonstrates significant improvement in glucose control and cholesterol levels among One Medical patients with previously uncontrolled diabetes Peer-reviewed study demonstrates significant improvement in glucose control and cholesterol levels among One Medical patients with previously uncontrolled diabetes

Longitudinal Study Finds One Medical's Member-Based & Technology-Powered Primary Care Model Delivers Outsized Impact in Controlling Diabetes

After its most recent earnings call in May, One Medical appears to have lost its immediate stock market luster.  When the San Francisco-based primary care company reported that its losses per share were double what analysts expected, the company's stock dropped 8.4% in after-hours trading – a sign some investors are skittish about One Medical's financial future.

Analysts are optimistic that primary-care upstart One Medical can shake off its stock-market slump

Bloomin' Brands

Amicus Therapeutics

Seagate Technology Holdings PLC

Apellis Pharma

Children's Place

Sabra Health Care

With the trading day more than halfway over, the markets were somewhat mixed going into the weekend.

Amicus, Bloomin' Brands, Seagate and More Friday Afternoon Analyst Calls

One of the ARK Invest exchange-traded funds run by ETF star Cathie Wood made a huge purchase on Thursday.

Cathie Wood's ARK Invest Buys Over 1.1 Million Shares of 1Life Healthcare

1Life Healthcare Inc. , which operates the One Medical direct primary care business, on Wednesday told investors that it started seeing a "meaningful drop" in COVID-19 testing in April as a greater number of Americans were vaccinated against the virus and the number of coronavirus cases in the U.S. continued to decline. 1Life CFO Bjorn Thaler cited a "faster-than-anticipated education in COVID-19 testing volumes," according to a FactSet transcript of the company's first-quarter earnings call.

One Medical's parent company says COVID-19 testing volume 'meaningfully' declined in April

1Life Healthcare, Inc. (ONEM) CEO Amir Dan Rubin on Q1 2021 Results - Earnings Call Transcript

News for 1Life Healthcare Stock (ONEM)